OUTCOMES OF ATRIO-ESOPHAGEAL FISTULA FOLLOWING CATHETER ABLATION OF ATRIAL FIBRILLATION TREATED WITH SURGICAL REPAIR VERSUS ESOPHAGEAL STENTING  by Mohanty, Sanghamitra et al.
A273
JACC April 1, 2014
Volume 63, Issue 12
Arrhythmias and Clinical EP
outcomEs of atrio-EsophagEaL fistuLa foLLowing cathEtEr abLation of atriaL 
fibriLLation trEatEd with surgicaL rEpair VErsus EsophagEaL stEnting
Moderated Poster Contributions
Hall C
Saturday, March 29, 2014, 4:00 p.m.-4:15 p.m.
Session Title: Devices for Arrhythmia Management: Novel Considerations
Abstract Category: 4. Arrhythmias and Clinical EP: AF/SVT
Presentation Number: 1162M-359B
Authors: Sanghamitra Mohanty, Pasquale Santangeli, Prasant Mohanty, Luigi Di Biase, Chintan Trivedi, Rong Bai, Rodney Horton, John Burkhardt, 
Javier Sanchez, Jason Zagrodzky, Shane Bailey, Joe Gallinghouse, Patrick Hranitzky, Albert Sun, Richard Hongo, Salwa Beheiry, Andrea Natale, 
Texas Cardiac Arrhythmia Institute, Austin, TX, USA
background: Atrioesophageal fistula (AEF) is a rare but devastating complication of radio-frequency catheter ablation (RFCA) of atrial fibrillation 
(AF). Surgical repair and esophageal stents are available treatment options for AEF. We report outcomes of these two management strategies.
methods: Nine patients with AEF post-RFCA for AF were included in this study. AEF was diagnosed based on symptoms and chest CT imaging. Of the 
9 patients, 5 received stent and 4 underwent surgical repair of fistula.
results: AF ablation was performed under general anesthesia (n=4) or conscious sedation (n=5). During ablation, RF power was maintained 
between 25 and 35 Watts in areas close to esophagus and energy delivery discontinued when esophageal temperature reached 38°C. Seven 
patients underwent ablation with 3.5-mm open-irrigated catheter, 1 with 8-mm non-irrigated catheter and 1 had surgical epicardial ablation. Seven 
patients received proton-pump inhibitor and sucralfate before and after procedure. AEF symptoms developed within 2-6 weeks from ablation. 
Esophageal stenting was performed in 5 patients (median age 58 years, median time from RFCA 4 weeks) and 4 underwent surgical repair (median 
age 54 years, median time from RFCA 4 weeks) within 2 to 4 hours from diagnosis. All five patients receiving stent died within one week of the 
procedure due to cerebral embolism, septic shock, or respiratory failure. On the other hand, the four patients that received surgical repair were alive 
at median follow-up of 2.1 years (p=0.005).
conclusions: Esophageal stenting should be discouraged and prompt surgical repair is crucial for survival in patients with atrio-esophageal fistula.
